- Buy The Bull Market
- Posts
- š 2 stocks I'm watching
š 2 stocks I'm watching
Michael Taylor
January 22, 2026
A lot can happen in a week.
Trump has decided that, after not being given the Nobel Peace Prize by Norwayās Prime Minister, who says he has repeatedly explained it is an independent decision, he is now no longer inclined to āto think purely of Peaceā.
Yes, you read that right.
He didnāt win the Nobel Peace Prize and is now threatening the very opposite of peace.
Which, actually, if you think about it, shows why he shouldnāt have been awarded it anyway.
But Iām sure this irony is lost on him.
I wrote last week that Denmark should explore a deal with Trump and maybe even consider selling it.
However, in a new update last night, Trump ruled out using force.
āPeople thought I would use force. I donāt have to use force. I donāt want to use force. I wonāt use forceā¦ We want a piece of ice for world protection, and they wonāt give itā.ā.ā.āThey have a choice. You can say yes and we will be very appreciative, or you can say no and we will remember.ā
This is a good thing.
Is it the typical Trump thing to do, throw lots of things around to obfuscate and confuse?
Probably.
But we wait and see what card he plays next.
Anpario (ANP)
As always, everything I write and say is my own personal opinion only. It is NOT financial advice.
I donāt accept money from listed companies to talk about them unlike other market commentators, so whilst this is independent nothing is a stock recommendation to buy or sell.
These are ideas only, and whilst I try to be balanced, sometimes I will be wrong.
Anpario is a UK-based company specialising in the manufacture of natural, sustainable feed additives designed to enhance animal health, nutrition, and biosecurity.
Itās primary focus is on understanding and improving animalsā intestinal health and nutrition, which makes it somewhat a unique company.
In any case, Anpario put out good news this week.
Itās beaten its expectations again.
Yet the price sold off.
This tells me that the āaheadā was expected, and so the price has come off a little.
However, the stock appears to be building a base with 520p being the breakout point.
The analyst consensus for FY 2025 before this RNS was revenue of Ā£45.5 million and adjusted EBITDA of Ā£8.2 million.
This is a reasonable beat in both revenue and adjusted EBITDA, yet the price hasnāt moved.
Iāve set an alarm towards the breakout level and will keep watching.
The next stock is a cheap commodities producer that is poised to do well if commodity prices keep printing higher and the final pick for 2026.
Reply